Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients.
Reina-Couto M, Roboredo-Madeira M, Pereira-Terra P, Silva-Pereira C, Martins S, Teixeira-Santos L, Pinho D, Dias A, Cordeiro G, Dias CC, Sarmento A, Tavares M, Guimarães JT, Roncon-Albuquerque R, Paiva JA, Albino-Teixeira A, Sousa T.
Reina-Couto M, et al. Among authors: martins s.
Inflamm Res. 2023 Mar;72(3):475-491. doi: 10.1007/s00011-022-01682-z. Epub 2023 Jan 8.
Inflamm Res. 2023.
PMID: 36617343
Free PMC article.